PTGS2 and head and neck squamous cell carcinoma: Bergmann and colleagues showed that prostaglandin-E2 (PGE2), a soluble product of cyclooxygenase-2 (COX-2) activity, is implicated in tumor immunosuppression in HNSCC, promoting the expansion of Tregs [53].